14 Biotech Stocks with High Potential

Page 5 of 13

9. Ocular Therapeutix Inc. (NASDAQ:OCUL)

Analyst Upside: 75.28%

Number of Hedge Fund Holders: 27

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best biotech stocks with high potential. On October 3, Piper Sandler raised the firm’s price target on Ocular Therapeutix Inc. (NASDAQ:OCUL) to $31 from $21 while keeping an Overweight rating on the shares.

The rating update came after the firm hosted Ocular Therapeutix Inc.’s (NASDAQ:OCUL) management at an investor dinner after its investor day, discussing aspects such as the newly disclosed diabetic retinopathy pivotal trial designs and the anticipated SOL-1 readout in Q1 2026.

The firm further stated that it raised its peak risk-adjusted sales estimates for AXPAXLI from $1.9 billion to $3.2 billion, based on the increased confidence in the wet AMD and NPDR Phase 3 programs.

Ocular Therapeutix Inc. (NASDAQ:OCUL) is a biopharmaceutical company that develops and commercializes therapies for conditions and diseases related to the eye. The company’s product pipeline includes Dextenza, OTX-TP, and OTX-TIC.

Page 5 of 13